FIELD: veterinary.
SUBSTANCE: composition contains glucosamine sulphate, methylsulphonylmethane, calcium ascorbate, willow extract, manganese citrate, auxiliary substances in grams per tablet with weight 0.93 g: glucosamine sulphate 0.50, methylsulphonylmethane 0.25, calcium ascorbate 0.10, willow extract 0.05, manganese citrate 0.01, auxiliary substances 0.02.
EFFECT: composition possesses increased anti-arthrosis action, reducing treatment terms, as well as expressed anti-inflammatory action.
1 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
FEED WITH GLUCOZAMIN AND WILLOW EXTRACT FOR PREVENTION OF ARTHROSIS IN ANIMALS | 2007 |
|
RU2361417C2 |
GLUCOSAMINE-CONTAINING COMPOSITION AS HYDROGEL | 2005 |
|
RU2303453C2 |
COMPOSITION STIMULATING REPARATIVE OSTEOGENESIS IN DOGS AND CATS | 2022 |
|
RU2785118C1 |
COMPOSITION - DRUG OF ANTIARTHROSIS AGENT GLUCOSEAMINE HYDROCHLORIDE FOR ORAL ADMINISTRATION | 1996 |
|
RU2130310C1 |
SPECIALIZED FOOD PRODUCT FOR MAINTAINING JOINTS AND DERMIS AND METHOD FOR MANUFACTURE THEREOF | 2017 |
|
RU2674590C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
COMPOSITION POSSESSING ANALGESIC, ANTI-INFLAMMATORY AND LOCOMOTOR FUNCTION IMPROVING ACTION | 2011 |
|
RU2468805C2 |
PHARMACEUTICAL COMPOSITION BASED ON VEGETATIVE DHA FOR TREATING AND PREVENTING DISEASES OF JOINTS | 2011 |
|
RU2478376C1 |
COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2381029C1 |
Authors
Dates
2009-07-10—Published
2006-11-07—Filed